About the Author

Dr. G. Suarez-Kurtz, is Head of Pharmacology at the Brazilian National Cancer Institute— INCA— Coordinator of the Brazilian National Pharmacogenomics Network— REFARGEN— and a member of the Committee on Pharmacogenetics of the International Union of Pharmacology— IUPHAR. A pioneer of pharmacogenetic studies in the Brazilian population, his research explores the impact o f genetic admixture on the conceptual development and the praxis of pharmacogenetics/-genomics. He is a Full Member of the Brazilian Academy of Sciences, a Senior Investigator of the Brazilian National Research Council— CNPq— and a Professor of Clinical and Basic Pharmacology at Universidade do Brasil in Rio de Janeiro, where he received his M.D. and Ph.D. degrees. He did postgraduate work at Faculté de Médecine de Paris, Columbia University, New York and University College, London.